Brett Sandercock

Chief Financial Officer

Brett Sandercock (Chief Financial Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in ResMed Inc. (RMD). The largest single filing was $823K of RMD (3,000 sh × $274.36, as filed), executed Oct 1 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.8M

shares × price, as filed

Last traded

Apr 1

Filed Apr 3

Median ADV $323.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

RMD

ResMed Inc. RMD · 0 buys · 19 sells 19 filings

Recent filings

RMDSALE ResMed Inc. View filing → $244K
1,000 sh × $244.23
Exec Dec 9 2024
Filed Dec 11 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $249K
1,000 sh × $249.00
Exec Nov 8 2024
Filed Nov 12 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $233K
1,000 sh × $233.47
Exec Oct 8 2024
Filed Oct 9 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $246K
1,000 sh × $246.42
Exec Sep 9 2024
Filed Sep 10 2024 · 5:30 PM ET